Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2017-06-08FDA Approved: GABAPENTIN — Supplemental Application (Acella Pharmaceuticals, LLC)
FDA approved a supplemental application for gabapentin from Acella Pharmaceuticals, LLC.
-
CLINICAL_TRIALS trial_result · 2017-06-05Clinical Trial Update: Progesterone vs Placebo Therapy for Women With Epilepsy [Phase 3]
A Phase 3 trial comparing progesterone versus placebo for women with epilepsy has completed; results have been posted.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 5mg×5 Compared With Lamotrigine Compressed Tablet 25mg in Chinese Healthy Male Subjects [Phase 1]
Phase 1 bioequivalence study comparing lamotrigine dispersible/chewable 5mg×5 with lamotrigine 25mg tablet in healthy Chinese male subjects …
-
CLINICAL_TRIALS trial_result · 2017-05-31Clinical Trial Update: Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy [Phase 3]
Phase 3 trial assessing the safety and tolerability of OXC XR as adjunctive therapy in adults with refractory partial epilepsy; results were…
-
FDA approval · 2017-05-30FDA Approved: FELBAMATE — Original Application (Zydus Lifesciences Limited)
FDA approved Felbamate from Zydus Lifesciences Limited under an Original Application (ANDA).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Lethargic Depression Study [Phase 3]
The Phase 3 Lethargic Depression Study, sponsored by GlaxoSmithKline, has completed. The study investigated epilepsy and major depressive di…
-
CLINICAL_TRIALS withdrawal · 2017-05-30Clinical Trial Update: Efficacy and Safety of the Use of Memantine for Preserving Cognition in Adult Patients With Epilepsy [NA]
A clinical trial evaluating memantine for preserving cognition in adults with epilepsy has been withdrawn.
-
CLINICAL_TRIALS research · 2017-05-23Clinical Trial Update: Impact of Early Lactate Dosage Compared to CK for Diagnosis of a Suspected Seizure
A clinical trial update evaluating whether early lactate measurement provides diagnostic value for suspected seizures compared with creatine…
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: A Conversion Study of Immediate Release (IR) and Modified Release (MR) Forms of Topiramate (TPM) [Phase 1]
This clinical trial update reports the completion of a Phase 1 study comparing immediate-release and modified-release topiramate for epileps…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Remegal Different Doses in Patients With Refractory Partial Seizures [Phase 2]
Phase 2 trial evaluating different doses of Remegal in patients with refractory partial seizures has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Remegal Fixed Dose as Adjunctive Therapy in Patients With Partial Seizures [Phase 3]
A Phase 3 trial of Remegal fixed-dose as adjunctive therapy for partial seizures has completed under sponsor Valexfarm.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: The Bioequivalence Study of Lamotrigine Dispersible/Chewable Tablets 100mg Compared With Compressed Tablet 100 mg [Phase 1]
Phase 1 bioequivalence study comparing lamotrigine dispersible/chewable 100 mg with lamotrigine 100 mg compressed tablet completed.
-
CLINICAL_TRIALS approval · 2017-05-09Clinical Trial Update: Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects
OXC XR has been approved for marketing for pediatric epilepsy based on a long-term safety study.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Effect of Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy [NA]
A clinical trial evaluating magnesium supplementation for children with drug-resistant idiopathic epilepsy has completed. The snippet does n…
-
CLINICAL_TRIALS trial_result · 2017-05-08Clinical Trial Update: Preliminary Testing of a Novel Device to Detect Epileptic Seizures
University of Edinburgh reports preliminary testing results of a novel device designed to detect epileptic seizures.
-
FDA approval · 2017-05-05FDA Approved: ETHOSUXIMIDE — Supplemental Application (PAI Holdings, LLC dba PAI Pharma)
FDA approved a supplemental application for Ethosuximide (PAI Pharma) to update the product labeling.
-
CLINICAL_TRIALS trial_result · 2017-05-05Clinical Trial Update: Lactic Acidosis During and After Seizures
Clinical trial update noting completion of a study and posted results regarding lactic acidosis during and after seizures.
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Ketogenic Diet in Infants With Epilepsy (KIWE) [Phase 4]
A Phase 4 clinical trial update on using a ketogenic diet to treat epilepsy in infants.
-
CLINICAL_TRIALS withdrawal · 2017-05-03Clinical Trial Update: Remote Tracking of Epilepsy Patients
The UCSF-sponsored clinical trial NCT01130649 on remote tracking of epilepsy patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-04-28Clinical Trial Update: The Utility of NIOM During LITT for Refractory MTLE [NA]
The clinical trial NCT02913742 exploring NIOM during LITT for refractory mesial temporal lobe epilepsy has been withdrawn.
-
FDA approval · 2017-04-27FDA Approved: SABRIL — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for Sabril (vigabatrin) from Lundbeck Pharmaceuticals LLC.
-
CLINICAL_TRIALS withdrawal · 2017-04-27Clinical Trial Update: Mainstream Sleep Tracking Devices vs Polysomnography [NA]
A clinical trial comparing mainstream sleep tracking devices to polysomnography was withdrawn, involving obstructive sleep apnea, insomnia, …
-
FDA approval · 2017-04-27FDA Approved: VIGABATRIN — Original Application (Par Health USA, LLC)
FDA approves Vigabatrin original Abbreviated New Drug Application for Par Health USA, LLC (generic entry).
-
FDA approval · 2017-04-25FDA Approved: LAMOTRIGINE — Supplemental Application (Torrent Pharmaceuticals Limited)
The FDA approved a supplemental application for Lamotrigine from Torrent Pharmaceuticals Limited (ANDA203370). The action updates the produc…
-
CLINICAL_TRIALS trial_result · 2017-04-25Clinical Trial Update: Add on Lacosamide Versus High Dose Monotherapy [Phase 3]
Phase 3 trial comparing add-on lacosamide to high-dose monotherapy in epilepsy has completed. Results were posted in 2017.